Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Raphael Amado | Executive Vice President of Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Marc Frahm | Cowen and Company |
Salveen Richter | Goldman Sachs |
Biren Amin | Jefferies |
Tyler Van Buren | Piper Sandler |
Mark Breidenbach | Oppenheimer |
John Newman | Canaccord |
Reni Benjamin | JMP Securities |
Good morning, ladies and gentlemen, and thank you for standing by, and welcome to Allogene Therapeutics' Foruth Quarter 2019 Conference Call. [Operator Instructions] Please be aware, that today's conference is being recorded.
I would now like to turn the conference over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.